Increased frequency of interferon-γ-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection

被引:5
作者
Kawakami, Y [1 ]
Nabeshima, S [1 ]
Furusyo, N [1 ]
Sawayama, Y [1 ]
Hayashi, J [1 ]
Kashiwagi, S [1 ]
机构
[1] Kyushu Univ Hosp, Dept Gen Med, Higashi Ku, Fukuoka 8128582, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: To determine the profile of cytokine secretion by CD4(+) T helper (Th) cells in chronic hepatitis C virus (HCV) infection, we used flow cytometry to determine the percentage of interferon (IFN)-gamma and interleukin (IL)-4 producing cells from CD4+ T lymphocytes in peripheral blood obtained from patients chronically infected with HCV. METHODS: Peripheral blood mononuclear cells isolated from 89 HCV infected subjects (22 asymptomatic carriers, 56 patients with chronic hepatitis, and II patients with liver cirrhosis) and 34 healthy controls were stained with surface CD4 and intracellular IFN-gamma and IL-4. Serum soluble IL-2 receptor (sIL-2R) levels were analyzed by ELISA. RESULTS: The frequency of IFN-gamma producing CD4(+) cells in asymptomatic HCV carriers, patients with chronic hepatitis, and patients with liver cirrhosis were significantly higher than those of healthy controls (p < 0.01, respectively). In contrast, the percentages of IL-4-producing CD4+ cells were very low, and there were no significant correlations with disease progression. A significant elevation in serum sIL-2R levels was found in chronic HCV infection compared to healthy controls, and serum sIL-2R levels significantly correlated with the frequency of IFN-gamma-producing cells. CONCLUSIONS: In HCV infected subjects, both serum sIL-2R and IFN-gamma are increased in chronic HCV infection no matter the stage of disease, meaning they are no different in asymptomatic carriers, patients with chronic hepatitis, and patients with liver cirrhosis, and that Th1 cytokine or Th1 cells may participate in the pathogenesis of liver damage in chronic HCV infection. (Am J Gastroenterol 2000;95:227-232. (C) 2000 by Am. Cell. of Gastroenterology)
引用
收藏
页码:227 / 232
页数:6
相关论文
共 47 条
[1]
BANCROFT GJ, 1987, J IMMUNOL, V139, P1104
[2]
Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections [J].
Bertoletti, A ;
DElios, MM ;
Boni, C ;
DeCarli, M ;
Zignego, AL ;
Durazzo, M ;
Missale, G ;
Penna, A ;
Fiaccadori, F ;
DelPrete, G ;
Ferrari, C .
GASTROENTEROLOGY, 1997, 112 (01) :193-199
[3]
Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa [J].
Cacciarelli, TV ;
Martinez, OM ;
Gish, RG ;
Villanueva, JC ;
Krams, SM .
HEPATOLOGY, 1996, 24 (01) :6-9
[4]
Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus [J].
Chang, KM ;
Rehermann, B ;
McHutchison, JG ;
Pasquinelli, C ;
Southwood, S ;
Sette, A ;
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2376-2385
[5]
ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[6]
THE ROLE OF HELPER T-CELL PRODUCTS IN MOUSE B-CELL DIFFERENTIATION AND ISOTYPE REGULATION [J].
COFFMAN, RL ;
SEYMOUR, BWP ;
LEBMAN, DA ;
HIRAKI, DD ;
CHRISTIANSEN, JA ;
SHRADER, B ;
CHERWINSKI, HM ;
SAVELKOUL, HFJ ;
FINKELMAN, FD ;
BOND, MW ;
MOSMANN, TR .
IMMUNOLOGICAL REVIEWS, 1988, 102 :5-28
[7]
STIMULATORY AND INHIBITORY EFFECTS OF INTERLEUKIN (IL)-4 AND IL-13 ON THE PRODUCTION OF CYTOKINES BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRIMING FOR IL-12 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION [J].
DANDREA, A ;
MA, XJ ;
ASTEAMEZAGA, M ;
PAGANIN, C ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :537-546
[8]
TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL [J].
DAVIS, GL ;
BALART, LA ;
SCHIFF, ER ;
LINDSAY, K ;
BODENHEIMER, HC ;
PERRILLO, RP ;
CAREY, W ;
JACOBSON, IM ;
PAYNE, J ;
DIENSTAG, JL ;
VANTHIEL, DH ;
TAMBURRO, C ;
LEFKOWITCH, J ;
ALBRECHT, J ;
MESCHIEVITZ, C ;
ORTEGO, TJ ;
GIBAS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1501-1506
[9]
PURIFIED PROTEIN DERIVATIVE OF MYCOBACTERIUM-TUBERCULOSIS AND EXCRETORY-SECRETORY ANTIGEN(S) OF TOXOCARA-CANIS EXPAND INVITRO HUMAN T-CELLS WITH STABLE AND OPPOSITE (TYPE-1 T-HELPER OR TYPE-2 T-HELPER) PROFILE OF CYTOKINE PRODUCTION [J].
DELPRETE, GF ;
DECARLI, M ;
MASTROMAURO, C ;
BIAGIOTTI, R ;
MACCHIA, D ;
FALAGIANI, P ;
RICCI, M ;
ROMAGNANI, S .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :346-350
[10]
DI BA, 1989, NEW ENGL J MED, V321, P1506